Several compelling examples highlight the complexity of inhibiting HSP47 and emphasize the need for caution: The impact of HSP47 on bone integrity in OI, its potential necessity in hyperthermia (HT)-based cancer therapies, but also the potential impact on bleeding or autoimmune disorders. The gene discussed is SERPINH1; the disease is Autoimmunity.